Results 191 to 200 of about 4,321,640 (219)
Some of the next articles are maybe not open access.
Pharmacokinetics of anti-D IgG in pregnant RhD-negative women.
BJOG : an international journal of obstetrics and gynaecology, 2003To assess the pharmacokinetics of anti-D IgG in pregnant Rhesus D-negative women after intramuscular and intravenous administration of 300 microg of Rhophylac.An open, randomised, multicentre study.Seven gynaecological practices in Germany.Fourteen RhD-negative pregnant women at risk of becoming Rhesus D immunised received study drug at 28th week of ...
Johann, Bichler +3 more
+5 more sources
Screening of RHD fetal genotype in RhD negative women.
Ceska gynekologie, 2021In the Czech Republic in all women within a first trimester screening a laboratory testing for RhD blood group from the peripheral blood should be performed. The aim of the screening is to diagnose RhD negative pregnant women, who may be at risk of developing RhD alloimmunization if the fetus is RhD positive.
T, Kratochvílová +6 more
openaire +1 more source
Frequency of DEL phenotype in RhD negative donor population of north India
Transfusion and Apheresis Science, 2015There is a paucity of data for DEL phenotype in the Indian population. Ours is a tertiary care Regional Blood Transfusion Centre in north India collecting more than 50,000 blood units out of which 8-9% are RhD negative donors.To determine the frequency of DEL phenotype in RhD negative blood donor population at our centre.A total of 200 RhD-negative ...
Sazia, Samir +2 more
openaire +2 more sources
[Guideline for prevention of RhD alloimmunization in RhD negative women].
Ceska gynekologie, 2010Events following which anti-D immunoglobulin should be given to all RhD negative women with no anti-D antibodies: First trimester indications (50 microg)--termination of pregnancy, spontaneous abortion followed by instrumentation, ectopic pregnancy, chorionic villus sampling, partial molar pregnancy; Second and third trimester indications (100 microg)--
M, Lubušký +3 more
openaire +2 more sources
Routine anti-D prophylaxis for RhD-negative pregnant women
British Journal of Midwifery, 2003Haemolytic disease of the newborn affects about 500 fetuses in England and Wales annually, and kills 25-30. In 1999, the Royal College of Obstetricians and Gynaecologists published guidelines recommending routine antenatal anti-D prophylaxis of at least 500 IU at 28 and 34 weeks’ gestation for all Rhesus D (RhD)-negative women. This recommendation has
openaire +1 more source
Pharmacokinetics and safety of recombinant anti‐RhD in healthy RhD‐negative male volunteers
Transfusion Medicine, 2004summary In this first‐in‐man study, we assessed the pharmacokinetics, safety and tolerability of MonoRho, a human recombinant monoclonal anti‐RhD immunoglobulin G1 (IgG1) antibody. Eighteen RhD‐negative healthy male volunteers were randomized in two groups to receive a single administration of 300 µg of MonoRho either intravenously or intramuscularly ...
J, Bichler +5 more
openaire +2 more sources
PURL: A new protocol for RhD-negative pregnant women?
The Journal of family practice, 2019Can cell-free DNA testing reduce unnecessary use of anti-D immunoglobulin in RhD-negative women and still prevent harm to their RhD-positive infants?
Corey, Lyon, Aimee, English
openaire +1 more source
[Genotype analysis of RhD-negative donors with immune antibodies].
Zhongguo shi yan xue ye xue za zhi, 2013In order to analyze the genotype of RhD-negative blood donors with immune antibodies in Harbin, the voluntary blood donors from 1 April 2008 to 30 september 2011 were detected serologically to determine the RhD-negative donors. The blood donors confirmed to be RhD negative were detected to screen the immune antibodies, the samples with immune ...
Chun-Yan, Zhang +3 more
openaire +1 more source
Artificial insemination in RhD negative women
Human Reproduction, 1995M.A. Greiss, P. Terry, S.J. Urbaniak
openaire +1 more source

